Additionally, the oral anti-diabetic dipeptidyl peptidase-4 (DPP-IV) inhibitor sitagliptin may prolong telomere length in patients with T2DM, as has been assumed for the incretin hormone glucagon-like peptide 1 (GLP-1) [52]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.